Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thomas Nahass

Showing results (1-10 of 1) with videos related to

Pageof 1
Sort By:
ERJ Open Research|October 12, 2020
Observational study of the use of recombinant tissue-type plasminogen activator in COVID-19 shows a decrease in physiological dead spaceSarah Orfanos, Ibrahim El Husseini, Thomas Nahass, et al.
Pageof 1

Showing results (1-10 of 1) with videos related to

Sort By:
Pageof 1
ERJ Open Research|October 12, 2020
Observational study of the use of recombinant tissue-type plasminogen activator in COVID-19 shows a decrease in physiological dead spaceSarah Orfanos, Ibrahim El Husseini, Thomas Nahass, et al.
Pageof 1